ASE: HPIC Statistics

Total Valuation

Hayat Pharmaceutical Industries Co. has a market cap or net worth of JOD 23.75 million. The enterprise value is 20.31 million.

Market Cap	23.75M
Enterprise Value	20.31M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Hayat Pharmaceutical Industries Co. has 9.50 million shares outstanding. The number of shares has increased by 3.55% in one year.

Current Share Class	n/a
Shares Outstanding	9.50M
Shares Change (YoY)	+3.55%
Shares Change (QoQ)	-9.32%
Owned by Insiders (%)	56.77%
Owned by Institutions (%)	n/a
Float	1.43M

Valuation Ratios

The trailing PE ratio is 8.35.

PE Ratio	8.35
Forward PE	n/a
PS Ratio	1.50
PB Ratio	0.83
P/TBV Ratio	0.83
P/FCF Ratio	54.61
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.33, with an EV/FCF ratio of 46.70.

EV / Earnings	6.90
EV / Sales	1.24
EV / EBITDA	4.33
EV / EBIT	5.68
EV / FCF	46.70

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.12.

Current Ratio	4.47
Quick Ratio	3.03
Debt / Equity	0.12
Debt / EBITDA	0.73
Debt / FCF	7.87
Interest Coverage	28.68

Financial Efficiency

Return on equity (ROE) is 10.54% and return on invested capital (ROIC) is 7.27%.

Return on Equity (ROE)	10.54%
Return on Assets (ROA)	6.53%
Return on Capital (ROIC)	7.27%
Revenue Per Employee	69,560
Profits Per Employee	12,480
Employee Count	236
Asset Turnover	0.48
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.46%
50-Day Moving Average	2.54
200-Day Moving Average	2.50
Relative Strength Index (RSI)	43.57
Average Volume (20 Days)	22,731

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hayat Pharmaceutical Industries Co. had revenue of JOD 16.42 million and earned 2.95 million in profits. Earnings per share was 0.30.

Revenue	16.42M
Gross Profit	10.09M
Operating Income	3.58M
Pretax Income	3.45M
Net Income	2.95M
EBITDA	4.69M
EBIT	3.58M
Earnings Per Share (EPS)	0.30

Full Income Statement

Balance Sheet

The company has 6.87 million in cash and 3.42 million in debt, giving a net cash position of 3.44 million or 0.36 per share.

Cash & Cash Equivalents	6.87M
Total Debt	3.42M
Net Cash	3.44M
Net Cash Per Share	0.36
Equity (Book Value)	28.63M
Book Value Per Share	3.01
Working Capital	17.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.19 million and capital expenditures -750,679, giving a free cash flow of 434,910.

Operating Cash Flow	1.19M
Capital Expenditures	-750,679
Free Cash Flow	434,910
FCF Per Share	0.05

Full Cash Flow Statement

Margins

Gross margin is 61.45%, with operating and profit margins of 21.79% and 17.94%.

Gross Margin	61.45%
Operating Margin	21.79%
Pretax Margin	21.03%
Profit Margin	17.94%
EBITDA Margin	28.56%
EBIT Margin	21.79%
FCF Margin	2.65%

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 6.60%.

Dividend Per Share	0.17
Dividend Yield	6.60%
Dividend Growth (YoY)	-34.00%
Years of Dividend Growth	n/a
Payout Ratio	53.22%
Buyback Yield	-3.55%
Shareholder Yield	3.05%
Earnings Yield	11.98%
FCF Yield	1.83%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hayat Pharmaceutical Industries Co. has an Altman Z-Score of 4.16.

Altman Z-Score	4.16
Piotroski F-Score	n/a